159 related articles for article (PubMed ID: 21396841)
1. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.
Yin B; Liu G; Wang XS; Zhang H; Song YS; Wu B
Urol Oncol; 2012; 30(6):886-92. PubMed ID: 21396841
[TBL] [Abstract][Full Text] [Related]
2. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
Geng L; Yu LZ; Du P; Ma M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.
Yin B; Zeng Y; Wang X; Liu G; Zhang M; Song Y
Int J Clin Exp Pathol; 2014; 7(7):4112-9. PubMed ID: 25120790
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
[TBL] [Abstract][Full Text] [Related]
5. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
[TBL] [Abstract][Full Text] [Related]
6. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
[TBL] [Abstract][Full Text] [Related]
7. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
[TBL] [Abstract][Full Text] [Related]
10. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
11. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
Amsellem-Ouazana D; Bièche I; Molinié V; Elie C; Vieillefond A; Tozlu S; Botto H; Debré B; Lidereau R
Eur Urol; 2006 Jun; 49(6):1035-42; discussion 1042-3. PubMed ID: 16466848
[TBL] [Abstract][Full Text] [Related]
12. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J
Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253
[TBL] [Abstract][Full Text] [Related]
13. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
15. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
16. Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
Lerut E; Van Poppel H; Joniau S; Gruselle O; Coche T; Therasse P
Int J Clin Exp Pathol; 2015; 8(8):9522-32. PubMed ID: 26464715
[TBL] [Abstract][Full Text] [Related]
17. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
18. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F
Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039
[TBL] [Abstract][Full Text] [Related]
19. [Expression of MAGE-B genes in hepatocellular carcinoma].
Mou DC; Leng XS; Peng JR; Zhao L; Wang WX; Wang Y; Li T; Zhang LG; Huang L; Zhu JY
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):40-2. PubMed ID: 15059354
[TBL] [Abstract][Full Text] [Related]
20. [Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof].
Song T; Hong BF; Gao JP; Cai W; Wang CY
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):806-7. PubMed ID: 17565859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]